Spectrum Announces Launch of New Patient-to-Patient Educational Campaign for ... MarketWatch (press release) While the overall re-launch campaign will continue to focus on physicians with "RRZ" (rituximab, rituximab, ZEVALIN), additional emphasis will be placed on direct-to-patient outreach and patient-to-patient education. “The stories of these patients on ... |
